Ben Greenfield Documents Young Plasma Exchange and Six Regenerative Therapies
Biohacker Ben Greenfield undergoes plasma exchange with young donor blood plus five other cutting-edge longevity treatments.
20 articles
Biohacker Ben Greenfield undergoes plasma exchange with young donor blood plus five other cutting-edge longevity treatments.
Randomized trials and case reports reveal stool transplants may treat conditions far beyond gut disease — including mental health and addiction.
Mike Lustgarten explores how lab-based parabiosis models may reveal the blood factors that drive or reverse aging.
A Brazilian lab attempts to reproduce headline-making pig plasma rejuvenation results in rats — here's what they found.
Biohacker Ben Greenfield shares his three-day regenerative therapy journey including young plasma replacement and multiple longevity protocols.
Biohacker Ben Greenfield documents his three-day regenerative medicine experience including young plasma exchange and advanced longevity protocols.
Health biohacker Ben Greenfield undergoes cutting-edge longevity treatments including young plasma exchange and stem cell therapy.
Dr. Khanh Nguyen reveals cutting-edge plasma exchange therapies and stem cell protocols only available in Texas.
Dr. Khanh Nguyen reveals how young plasma infusions and therapeutic plasma exchange are revolutionizing anti-aging medicine.
KiraGen Bio is using multiplex gene editing and AI to build next-gen CAR-T therapies that could finally crack solid tumors like glioblastoma.
Revolutionary gene-editing technology CRISPR becomes available outside the US, offering new hope for treating genetic diseases worldwide.
New research reveals how fecal transplants from 100-year-olds may slow aging, while your own microbiome can help maintain weight loss.
Retro Biosciences used GPT-4b micro to engineer proteins that reverse cellular aging far more powerfully than evolution ever managed.
Dr. Matt Cook reveals breakthrough MUSE cells that home to damaged tissue 15x better than MSCs, plus peptide protocols and precision medicine advances.
UCSF scientist reveals how engineered T-cells and CRISPR are transforming cancer treatment and prevention strategies.
Brian Johnson's tirzepatide experiment sparked interest in microdosing GLP-1s for anti-aging, but evidence remains hypothetical with real risks.
Fitness expert Ben Greenfield explores the ethics of modern biohacking through a biblical and practical framework.
Health optimizer shares one-year experience with high-dose astaxanthin supplementation and the research behind its anti-aging benefits.
Retatrutide shows unprecedented weight loss results in phase 3 trials, but higher side effects may limit its advantage over existing medications.
Functional medicine founder Dr. Jeffrey Bland debates supplement critic Robyn Openshaw on whether modern supplementation helps or harms.